Guardian Pharmacy Services (GRDN) Earnings Date, Estimates & Call Transcripts $22.94 +0.07 (+0.31%) As of 03:58 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Guardian Pharmacy Services Earnings Summary Upcoming Q4 Earnings DateJun. 25After Market ClosesEstimatedConsensus EPS (Nov. 12) $0.19 Actual EPS (Nov. 12) -$2.00 Missed By -$2.19 Actual Revenue (Nov. 12) $314.39MGuardian Pharmacy Services announced Q3 2024 earnings on November 12, 2024, reporting an EPS of -$2.00, which missed the consensus estimate of $0.19 by $2.19. Quarterly revenue was reported to be $314.39 million, above the consensus estimate of $303.21 million. With a trailing EPS of $0.00, Guardian Pharmacy Services' earnings are expected to decrease -3.45% next year, from $0.87 to $0.84 per share. Q3 2024 Earnings ResourcesQ3 2024 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)GRDN Upcoming EarningsGuardian Pharmacy Services' next earnings date is estimated for Wednesday, June 25, 2025, based on past reporting schedules. Powered by Get Guardian Pharmacy Services Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Guardian Pharmacy Services and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Remove Ads Guardian Pharmacy Services Analyst EPS EstimatesCurrent Year EPS Consensus Estimate $0.87 EPSNext Year EPS Consensus Estimate $0.84 EPS Remove Ads Guardian Pharmacy Services Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 6/25/2025(Estimated)--------11/12/2024Q3 2024$0.19-$2.00 -$2.19-$2.00$303.21M$314.39M Guardian Pharmacy Services Earnings - Frequently Asked Questions When is Guardian Pharmacy Services's earnings date? Guardian Pharmacy Services has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 25th, 2025 based off last year's report dates. Learn more on GRDN's earnings history. What guidance has Guardian Pharmacy Services issued on next quarter's earnings? Guardian Pharmacy Services updated its FY 2025 earnings guidance on Monday, March, 3rd. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.3 billion. Did Guardian Pharmacy Services beat their earnings estimates last quarter? In the previous quarter, Guardian Pharmacy Services (NYSE:GRDN) missed the analysts' consensus estimate of $0.19 by $2.19 with a reported earnings per share (EPS) of ($2.00). Learn more on analysts' earnings estimate vs. GRDN's actual earnings. How can I listen to Guardian Pharmacy Services's earnings conference call? The conference call for Guardian Pharmacy Services's latest earnings report can be listened to online. Listen to Conference Call How can I read Guardian Pharmacy Services's conference call transcript? The conference call transcript for Guardian Pharmacy Services's latest earnings report can be read online. Read Transcript How much revenue does Guardian Pharmacy Services generate each year? Guardian Pharmacy Services (NYSE:GRDN) has a recorded annual revenue of $1.23 billion. What is Guardian Pharmacy Services's EPS forecast for next year? Guardian Pharmacy Services's earnings are expected to decrease from $0.87 per share to $0.84 per share in the next year, which is a -3.45% change. More Earnings Resources from MarketBeat Related Companies MNSO Earnings Results RUSHB Earnings Results W Earnings Results BOOT Earnings Results TBBB Earnings Results ASO Earnings Results CSAN Earnings Results RVLV Earnings Results VSCO Earnings Results GO Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NYSE:GRDN) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardian Pharmacy Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardian Pharmacy Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
